A
$ Value
—
Shares
24,116
Price
—
Filed
Feb 26
Insider
Name
Werner Sean
Title
Chief Technology Officer
CIK
0002047541
Roles
Officer
Transaction Details
Transaction Date
2026-02-24
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,043
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.
Filing Info
Werner Sean's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-19 | BLFS | F | $32K |
| 2026-03-03 | BLFS | ▼ | $2K |
| 2026-02-24 | BLFS | A | — |
| 2025-11-25 | BLFS | ▼ | $3K |
| 2025-10-20 | BLFS | ▼ | $8K |
| 2025-09-11 | BLFS | ▼ | $2K |
| 2025-08-26 | BLFS | ▼ | $3K |
| 2025-07-18 | BLFS | ▼ | $24K |
| 2025-06-10 | BLFS | ▼ | $2K |
| 2025-05-28 | BLFS | ▼ | $2K |
Other Insiders at BLFS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
DE GREEF RODERICK
President and CEO
|
— | — | 2026-03-19 |
| GOSWAMI JOYDEEP | — | — | 2026-02-24 |
|
Mathew Aby J.
EVP & Chief Scientific Officer
|
— | $11K | 2026-04-08 |
| Ellingson Rachel | — | — | 2026-02-24 |
| Hunt Anthony | — | — | 2026-02-24 |
|
Berard Todd
Chief Marketing Officer
|
— | $7K | 2026-04-08 |
| MOORE TIMOTHY L. | — | — | 2026-02-24 |
|
Foster Karen A.
Chief Quality and Operations
|
— | $2.0M | 2026-03-23 |
| Coste Catherine | — | — | 2026-02-24 |
|
Aebersold Sarah
Chief Human Resources Officer
|
— | $5K | 2026-03-19 |
| DuRoss Amy | — | — | 2026-02-24 |
|
Wichterman Troy
Chief Financial Officer
|
— | $12K | 2026-04-08 |
|
Werner Sean
Chief Technology Officer
|
— | $2K | 2026-03-19 |